(Q28191087)

English

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin

scientific article (publication date: 2001)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin (English)

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1

object named as

A Algra

0 references

author name string

E L de Schryver

2

0 references

J van Gijn

3

0 references

L J Kappelle

4

0 references

P J Koudstaal

5

0 references

language of work or name

0 references

publication date

2001

0 references

Cochrane Database of Systematic Reviews

0 references

4

0 references

CD001342

0 references

Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

ESPRIT: protocol change.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Anticoagulant therapy in cerebrovascular disease: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Control of oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001342

21 January 2018

Identifiers

10.1002/14651858.CD001342

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28191087&oldid=1386577722"